Diabetic Foot Ulcer Therapeutics Market - Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: D68338F9736BEN
Market Monitor Global

Abstracts

Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing breakthrough advanced wound dressings for diabetic foot ulcer management. This includes novel dressings with the ability to confer moisture balance with prolonged time of action, extended oxygen permeability, antimicrobial activity, growth factor stimulation, and the ability to promote autolytic debridement thus facilitating the re-epithelialization process. This factor is creating robust development in the global diabetic foot ulcer therapeutics market.

This report contains market size and forecasts of Diabetic Foot Ulcer Therapeutics in Global, including the following market information:

Global Diabetic Foot Ulcer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Diabetic Foot Ulcer Therapeutics market was valued at 4347.2 million in 2021 and is projected to reach US$ 6758.9 million by 2028, at a CAGR of 6.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Advance Wound Dressings Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetic Foot Ulcer Therapeutics include B.Braun Melsungen, Smith & Nephew, Organogenesis, Derma Sciences, Sigvaris, 3M, Acelity, Innocoll Holdings and SIGVARIS and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Foot Ulcer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetic Foot Ulcer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Foot Ulcer Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Advance Wound Dressings
• Skin Substitutes
• Negative Pressure Wound Therapy Devices
• Growth Factors

Global Diabetic Foot Ulcer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Foot Ulcer Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialty Clinics
• Long-Term Care Centers
• Ambulatory Surgical Centers

Global Diabetic Foot Ulcer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetic Foot Ulcer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diabetic Foot Ulcer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Diabetic Foot Ulcer Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• B.Braun Melsungen
• Smith & Nephew
• Organogenesis
• Derma Sciences
• Sigvaris
• 3M
• Acelity
• Innocoll Holdings
• SIGVARIS
• Osiris

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diabetic Foot Ulcer Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diabetic Foot Ulcer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIABETIC FOOT ULCER THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Diabetic Foot Ulcer Therapeutics Market Size: 2021 VS 2028
2.2 Global Diabetic Foot Ulcer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diabetic Foot Ulcer Therapeutics Players in Global Market
3.2 Top Global Diabetic Foot Ulcer Therapeutics Companies Ranked by Revenue
3.3 Global Diabetic Foot Ulcer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Foot Ulcer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetic Foot Ulcer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Foot Ulcer Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Diabetic Foot Ulcer Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diabetic Foot Ulcer Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Diabetic Foot Ulcer Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Advance Wound Dressings
  4.1.3 Skin Substitutes
  4.1.4 Negative Pressure Wound Therapy Devices
  4.1.5 Growth Factors
4.2 By Type - Global Diabetic Foot Ulcer Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Diabetic Foot Ulcer Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Diabetic Foot Ulcer Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diabetic Foot Ulcer Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Specialty Clinics
  5.1.4 Long-Term Care Centers
  5.1.5 Ambulatory Surgical Centers
5.2 By Application - Global Diabetic Foot Ulcer Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Diabetic Foot Ulcer Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Diabetic Foot Ulcer Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Diabetic Foot Ulcer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Foot Ulcer Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Diabetic Foot Ulcer Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Diabetic Foot Ulcer Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Diabetic Foot Ulcer Therapeutics Revenue, 2017-2028
  6.3.2 US Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.3.3 Canada Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Diabetic Foot Ulcer Therapeutics Revenue, 2017-2028
  6.4.2 Germany Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.4.3 France Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.4.5 Italy Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.4.6 Russia Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Diabetic Foot Ulcer Therapeutics Revenue, 2017-2028
  6.5.2 China Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.5.3 Japan Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.5.6 India Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Diabetic Foot Ulcer Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diabetic Foot Ulcer Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.7.3 Israel Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028
  6.7.5 UAE Diabetic Foot Ulcer Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 B.Braun Melsungen
  7.1.1 B.Braun Melsungen Corporate Summary
  7.1.2 B.Braun Melsungen Business Overview
  7.1.3 B.Braun Melsungen Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.1.4 B.Braun Melsungen Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 B.Braun Melsungen Key News
7.2 Smith & Nephew
  7.2.1 Smith & Nephew Corporate Summary
  7.2.2 Smith & Nephew Business Overview
  7.2.3 Smith & Nephew Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.2.4 Smith & Nephew Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Smith & Nephew Key News
7.3 Organogenesis
  7.3.1 Organogenesis Corporate Summary
  7.3.2 Organogenesis Business Overview
  7.3.3 Organogenesis Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.3.4 Organogenesis Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Organogenesis Key News
7.4 Derma Sciences
  7.4.1 Derma Sciences Corporate Summary
  7.4.2 Derma Sciences Business Overview
  7.4.3 Derma Sciences Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.4.4 Derma Sciences Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Derma Sciences Key News
7.5 Sigvaris
  7.5.1 Sigvaris Corporate Summary
  7.5.2 Sigvaris Business Overview
  7.5.3 Sigvaris Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.5.4 Sigvaris Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Sigvaris Key News
7.6 3M
  7.6.1 3M Corporate Summary
  7.6.2 3M Business Overview
  7.6.3 3M Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.6.4 3M Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 3M Key News
7.7 Acelity
  7.7.1 Acelity Corporate Summary
  7.7.2 Acelity Business Overview
  7.7.3 Acelity Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.7.4 Acelity Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Acelity Key News
7.8 Innocoll Holdings
  7.8.1 Innocoll Holdings Corporate Summary
  7.8.2 Innocoll Holdings Business Overview
  7.8.3 Innocoll Holdings Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.8.4 Innocoll Holdings Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Innocoll Holdings Key News
7.9 SIGVARIS
  7.9.1 SIGVARIS Corporate Summary
  7.9.2 SIGVARIS Business Overview
  7.9.3 SIGVARIS Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.9.4 SIGVARIS Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 SIGVARIS Key News
7.10 Osiris
  7.10.1 Osiris Corporate Summary
  7.10.2 Osiris Business Overview
  7.10.3 Osiris Diabetic Foot Ulcer Therapeutics Major Product Offerings
  7.10.4 Osiris Diabetic Foot Ulcer Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Osiris Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Diabetic Foot Ulcer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Diabetic Foot Ulcer Therapeutics Market Drivers in Global Market
Table 3. Diabetic Foot Ulcer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Diabetic Foot Ulcer Therapeutics in Global Market
Table 5. Top Diabetic Foot Ulcer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetic Foot Ulcer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetic Foot Ulcer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetic Foot Ulcer Therapeutics Product Type
Table 9. List of Global Tier 1 Diabetic Foot Ulcer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Foot Ulcer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetic Foot Ulcer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetic Foot Ulcer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetic Foot Ulcer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetic Foot Ulcer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. B.Braun Melsungen Corporate Summary
Table 31. B.Braun Melsungen Diabetic Foot Ulcer Therapeutics Product Offerings
Table 32. B.Braun Melsungen Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Smith & Nephew Corporate Summary
Table 34. Smith & Nephew Diabetic Foot Ulcer Therapeutics Product Offerings
Table 35. Smith & Nephew Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Organogenesis Corporate Summary
Table 37. Organogenesis Diabetic Foot Ulcer Therapeutics Product Offerings
Table 38. Organogenesis Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Derma Sciences Corporate Summary
Table 40. Derma Sciences Diabetic Foot Ulcer Therapeutics Product Offerings
Table 41. Derma Sciences Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Sigvaris Corporate Summary
Table 43. Sigvaris Diabetic Foot Ulcer Therapeutics Product Offerings
Table 44. Sigvaris Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. 3M Corporate Summary
Table 46. 3M Diabetic Foot Ulcer Therapeutics Product Offerings
Table 47. 3M Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Acelity Corporate Summary
Table 49. Acelity Diabetic Foot Ulcer Therapeutics Product Offerings
Table 50. Acelity Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Innocoll Holdings Corporate Summary
Table 52. Innocoll Holdings Diabetic Foot Ulcer Therapeutics Product Offerings
Table 53. Innocoll Holdings Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. SIGVARIS Corporate Summary
Table 55. SIGVARIS Diabetic Foot Ulcer Therapeutics Product Offerings
Table 56. SIGVARIS Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Osiris Corporate Summary
Table 58. Osiris Diabetic Foot Ulcer Therapeutics Product Offerings
Table 59. Osiris Diabetic Foot Ulcer Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Diabetic Foot Ulcer Therapeutics Segment by Type in 2021
Figure 2. Diabetic Foot Ulcer Therapeutics Segment by Application in 2021
Figure 3. Global Diabetic Foot Ulcer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Foot Ulcer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Foot Ulcer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Foot Ulcer Therapeutics Revenue in 2021
Figure 8. By Type - Global Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetic Foot Ulcer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetic Foot Ulcer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. B.Braun Melsungen Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Smith & Nephew Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Organogenesis Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Derma Sciences Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sigvaris Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. 3M Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Acelity Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Innocoll Holdings Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. SIGVARIS Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Osiris Diabetic Foot Ulcer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)